Developing a novel oral antibiotic to treat multidrug-resistant gonorrhea

Up to $2.86M has been awarded to a research team including Penn State scientists to develop a new oral antibiotic to treat multidrug-resistant gonorrhea, a sexually transmitted disease caused by bacteria that have developed resistance to all but one existing antibiotic.

A team including Penn State scientists has been awarded up to $2.86M to develop a new oral antibiotic to treat multidrug-resistant gonorrhea. Pictured is an illustration of the bacteria that causes gonorrhea, Neisseria gonorrhoeae. IMAGE: CENTERS FOR DISEASE CONTROL AND PREVENTION